Carlsmed Raises FY2026 Sales Guidance from $70.000M-$75.000M to $72.000M-$77.000M vs $72.807M Est

Benzinga Newsdesk www.benzinga.com Positive 93.7%

Neg 0% Neu 0% Pos 93.7%

Carlsmed (NASDAQ:CARL) raises FY2026 sales outlook from $70.000 million-$75.000 million to $72.000 million-$77.000 million vs $72.807 million estimate.